Lorraine Shack

Dr. Lorraine Shack



Adjunct Assistant Professor

Cumming School of Medicine, Department of Oncology


Arnie Charbonneau Cancer Institute

Director, Cancer Advance Analytics, Cancer Research & Analytics

Alberta Health Services

Contact information

Phone number

Office: 403.698.8116

Preferred method of communication

Admin Assistant

Penelope Timleck
Email: penelope.timleck@ahs.ca

Office: 780.643.4347



Dr. Shack is the Director of Cancer Advanced Analytics, Cancer Care Alberta, Alberta Health Services and is an Assistant Professor jointly in the Departments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary. She obtained her MSc and PhD from the London School of Hygiene and Medicine, England, completed the Executive Education program within Alberta Health Services as part of the 2018 cohort, and is a Certified Health Executive. She has worked in cancer epidemiology, prevention and surveillance in Scotland, England and Alberta, and currently leads the Cancer Advanced Analytics Department that combines the Alberta Cancer Registry, Data Integrity and Integration, and Surveillance & Reporting teams to support researchers, operations, planning and local/national/international studies in data and linkage to cancer data. She joined Alberta Health Services in 2009 (formerly Cancer Board) from the National Health Service, UK where she led cancer surveillance activities for the North West Cancer Intelligence Service, England. In these roles, and her current role as Director of Surveillance and Reporting, CancerControl Alberta, she has led cancer surveillance and epidemiology work within the health system. These projects have focused on epidemiology research based on cancer registry data and linkage with treatment, comorbidities, risk factors and follow-up with collaboration from clinical and population health experts. This work has included national and international research projects on cancer incidence and outcomes, such as the International Cancer Bench Marking Project, EUROCARE-4 and CONCORD (Global surveillance of cancer survival).

More recent work has focused on system performance measures, the use of administrative data to measure patient treatment pathways and outcomes/survival. She oversees the integration of data systems and more efficient linkage between existing data platforms, with the goal to increase capacity to manage a greater number and greater complexity of data requests. This is the hub of cancer information for AHS registering cancer diagnosis, analyzing and reporting and integrating the data for greater utilization. Dr. Shack also sits on the System Performance and Analytic Capacity Building Canadian Partnership Against Cancer Committees.



Areas of Research

Area of Focus
  • cancer
  • epidemiology
  • outcomes
  • surveillance
  • survival
Summary of Research

A large portion of Dr. Shack's work is focused on supporting operations, planning and policy through analytics using a combination of Cancer Registry data and other administrative date. Participation in previous and ongoing projects focused on Cancer data use, quality and comparability, in particular, surveillance, performance measures, linkage of cancer data, data warehouse development and cancer registry data quality have been key themes of my work. This has been explored in the International Cancer Benchmarking Project, Cancer Incidence in Five Continents (CONCORD 1 through 3) and the Canadian Partnership Against Cancer performance measures.


Anticipation of new and emerging opportunities in collecting, warehousing, and analyzing cancer patient data is the inspiration behind the upcoming (DECIDe). DECIDe will streamline data integration, access, and usability across several existing platforms and will be developed by Advanced Analytics, Cancer Research & Analytics in collaboration with AHS Data and Analytics and other key stakeholders. This will be the central source for cancer data in AHS and researchers.


The International Cancer Benchmarking Partnership (ICBP) is a unique and innovative collaboration that brings together clinicians, policymakers, researchers and data experts across the world. It is a collaboration of multiple countries/jurisdictions for which I am the Alberta PI. It aims to measure international variation in cancer survival, incidence and mortality, as well as identify factors that might be driving these differences. The ICBP used cancer registry data to provide a high quality international cancer survival benchmark and quantified the variation between participating ICBP countries. The ICBP also explored reasons behind the variation in survival rates.